Benitec Biopharma Inc.
BNTC
$13.59
-$0.305-2.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 284.23% | 162.30% | 1,953.53% | 115.89% | 93.36% |
| Total Receivables | -96.23% | -92.45% | 316.36% | -5.36% | -22.06% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.10% | -11.62% | -56.42% | -79.72% | -0.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 342.86% | 392.31% | 384.62% | -7.14% | 0.00% |
| Total Current Assets | 278.50% | 158.73% | 1,285.73% | 94.27% | 89.49% |
|
|
|||||
| Total Current Assets | 278.50% | 158.73% | 1,285.73% | 94.27% | 89.49% |
| Net Property, Plant & Equipment | -36.14% | -32.58% | -26.75% | -22.45% | -42.84% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -36.79% | -26.36% | -28.69% | -27.69% | -24.82% |
| Total Assets | 270.29% | 154.22% | 1,069.58% | 82.47% | 79.36% |
|
|
|||||
| Total Accounts Payable | -77.36% | -40.90% | 18.51% | 28.35% | 393.22% |
| Total Accrued Expenses | 12.58% | 28.32% | -13.04% | 1.99% | -28.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -52.10% | -24.64% | 3.27% | 8.55% | 8.75% |
| Total Finance Division Other Current Liabilities | -24.81% | 25.58% | 45.24% | 4.26% | 159.24% |
| Total Other Current Liabilities | -24.81% | 25.58% | 45.24% | 4.26% | 159.24% |
| Total Current Liabilities | -46.24% | 0.42% | 23.78% | 9.01% | 130.86% |
|
|
|||||
| Total Current Liabilities | -46.24% | 0.42% | 23.78% | 9.01% | 130.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -82.49% | -67.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -46.85% | -3.18% | 16.42% | -0.23% | 102.10% |
|
|
|||||
| Common Stock & APIC | 41.73% | 32.28% | 41.13% | 16.86% | 16.80% |
| Retained Earnings | -12.20% | -12.35% | -13.32% | -13.29% | -13.73% |
| Treasury Stock & Other | 27.73% | -27.31% | -7.47% | 2.11% | -6.01% |
| Total Common Equity | 390.89% | 187.70% | 23,290.10% | 144.01% | 72.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 390.89% | 187.70% | 23,290.10% | 144.01% | 72.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 390.89% | 187.70% | 23,290.10% | 144.01% | 72.00% |
|
|
|||||